Connected Hospitals Events, Seminars, & Publications 12. 06. 2023 ATTIKON, B Pre-educational Clinic, Director Professor Ms. Amanda Psirri.2nd Ambassador: Oncologist Ms. Panagiota Economopoulou. SOTIRIA, C Pathology Clinic, Director Professor Mr. Konstantinos Syrigos.Scientific Responsible – 2nd Ambassador: Oncologist Ms. Orianthi Fiste. General Hospital LARISSAS, Dental Department for Disabled, Director Mr. Grigorios Vlahakis, Scientific Responsible Ms. Paraskevi Siafaka.2nd Ambassador: Ms. Aikaterini Passa, Supervisor A. We sincerely thank and are grateful to the selected and prominent Hospitals of our Country, who chose to participate in the SymbIASIS program and to be associated with CureCancer - mycancer.gr.Our goal is to record and evaluate their demographic, social and economic needs as well as elements of their disease and treatment, which may affect the patients themselves and people with cancer experience, as well as their families. A particular innovation of CureCancer - mycancer.gr is the fact that the data is filled in by the patients themselves.
Advanced protocols for the management of high-risk patients Events, Seminars, & Publications 10. 02. 2026 Οστεονέκρωση Γνάθων (MRONJ): Από τη Θεωρία στην Πράξη - 3ο Webinar ΕξειδίκευσηςWhat Happened in the Previous Webinars?On January 16, 180 dentists attended the first webinar.On February 6, 174 dentists...[Read more]
Osteonecrosis of the Jaw (MRONJ): The 3-Step Safety System for Dentists Events, Seminars, & Publications 25. 06. 2026 How to Treat Patients Receiving Antiresorptive Medications with ConfidenceIn our previous webinars, hundreds of dentists discovered a system that has transformed the way they manage high-risk patients...[Read more]
Webinar for Medication-Related Osteonecrosis of the Jaw | June 5, 2026 Events, Seminars, & Publications 02. 04. 2026 On April 2nd, mycancer invites you to another online seminar focused on one of the most critical issues in modern Oncology:WEBINAR"Medication-Related Osteonecrosis of the Jaw in Cancer Therapy"Medicat...[Read more]